Boston Scientific said Monday it will pay medical device rival Johnson and Johnson $1.73 billion to settle several seven-year-old patent disputes over drug-coated stents.

Boston Scientific will pay Johnson & Johnson’s Cordis unit $1 billion this week and $725 million next January. The settlement resolves three patent disputes dating back to 2003, and avoids jury trials that were scheduled to begin later this month.